Funding

Xellar Biosystems

United States · Biotech · Healthtech · AI · Enterprise software

Develops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technology

Visit xellarbio.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$50MParticipants not disclosed

Investors

No participants disclosed.

Coverage

Jun 29, 2026Xellar Biosystems · Series A

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesxellarbio.com ↗